TipRanks
Go Ultimate55% OFF

Akebia Therapeutics (AX9) Cash flow

Akebia Therapeutics Cash Flow

DE:AX9's free cash flow for Q2 2026 was $2.45M. For the 2026 fiscal year, DE:AX9's free cash flow was decreased by $-1.08M and operating cash flow was $3.52M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 67.99M$ -40.66M$ -23.38M$ -73.15M$ -252.97M
$ -7.93M$ -33.00K$ 0.00$ -114.00K$ 39.94M
$ 72.93M$ 49.66M$ -25.21M$ 14.60M$ 133.73M
$ 186.54M$ 53.55M$ 44.58M$ 93.17M$ 151.84M
$ 67.99M$ -40.69M$ -23.38M$ -73.27M$ -253.02M

Currency in USD

Akebia Therapeutics Cash Flow

-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing